Eastern Asia - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingEastern Asia: Vaccine Market 2024
Vaccine Market Size in Eastern Asia
The East Asian vaccine market expanded remarkably to $X in 2022, picking up by 7.9% against the previous year. Over the period under review, consumption posted a resilient expansion. The level of consumption peaked at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.
Vaccine Production in Eastern Asia
In value terms, vaccine production expanded rapidly to $X in 2022 estimated in export price. Over the period under review, production enjoyed a buoyant expansion. The most prominent rate of growth was recorded in 2019 with an increase of 38%. Over the period under review, production hit record highs at $X in 2020; however, from 2021 to 2022, production failed to regain momentum.
Vaccine Exports
Exports in Eastern Asia
In 2022, after four years of growth, there was significant decline in shipments abroad of vaccines for human medicine, when their volume decreased by -26.7% to X tons. Overall, exports, however, continue to indicate a resilient expansion. The growth pace was the most rapid in 2021 when exports increased by 88% against the previous year. As a result, the exports reached the peak of X tons, and then shrank remarkably in the following year.
In value terms, vaccine exports contracted rapidly to $X in 2022. In general, exports, however, saw resilient growth. The pace of growth was the most pronounced in 2021 when exports increased by 78% against the previous year. As a result, the exports reached the peak of $X, and then plummeted in the following year.
Exports by Country
In 2022, South Korea (X tons) represented the main exporter of vaccines for human medicine, mixing up 61% of total exports. China (X tons) held a 22% share (based on physical terms) of total exports, which put it in second place, followed by Japan (11%). Taiwan (Chinese) (X tons) and Hong Kong SAR (X tons) followed a long way behind the leaders.
From 2012 to 2022, average annual rates of growth with regard to vaccine exports from South Korea stood at +4.4%. At the same time, Taiwan (Chinese) (+56.2%), China (+18.1%), Hong Kong SAR (+13.8%) and Japan (+12.9%) displayed positive paces of growth. Moreover, Taiwan (Chinese) emerged as the fastest-growing exporter exported in Eastern Asia, with a CAGR of +56.2% from 2012-2022. While the share of China (+13 p.p.), Taiwan (Chinese) (+4.3 p.p.) and Japan (+4.1 p.p.) increased significantly in terms of the total exports from 2012-2022, the share of South Korea (-22.2 p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.
In value terms, the largest vaccine supplying countries in Eastern Asia were South Korea ($X), China ($X) and Japan ($X), together comprising 88% of total exports. Taiwan (Chinese) and Hong Kong SAR lagged somewhat behind, together comprising a further 12%.
Among the main exporting countries, Taiwan (Chinese), with a CAGR of +50.6%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
The export price in Eastern Asia stood at $X per ton in 2022, growing by 6.6% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of +3.4%. The most prominent rate of growth was recorded in 2019 when the export price increased by 16%. Over the period under review, the export prices attained the peak figure in 2022 and is expected to retain growth in the immediate term.
There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Taiwan (Chinese) ($X per ton), while South Korea ($X per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (+7.7%), while the other leaders experienced more modest paces of growth.
Vaccine Imports
Imports in Eastern Asia
In 2022, approx. X tons of vaccines for human medicine were imported in Eastern Asia; approximately mirroring the previous year. Overall, imports enjoyed a strong increase. The growth pace was the most rapid in 2019 when imports increased by 76% against the previous year. The volume of import peaked at X tons in 2020; however, from 2021 to 2022, imports remained at a lower figure.
In value terms, vaccine imports shrank slightly to $X in 2022. In general, imports posted resilient growth. The pace of growth was the most pronounced in 2019 when imports increased by 117%. Over the period under review, imports hit record highs at $X in 2021, and then contracted slightly in the following year.
Imports by Country
In 2022, China (X tons) represented the largest importer of vaccines for human medicine, creating 62% of total imports. It was distantly followed by Japan (X tons), South Korea (X tons) and Taiwan (Chinese) (X tons), together making up a 34% share of total imports. Hong Kong SAR (X tons) held a relatively small share of total imports.
China was also the fastest-growing in terms of the vaccines for human medicine imports, with a CAGR of +14.7% from 2012 to 2022. At the same time, Taiwan (Chinese) (+9.2%) and Hong Kong SAR (+3.7%) displayed positive paces of growth. By contrast, Japan (-2.1%) and South Korea (-2.5%) illustrated a downward trend over the same period. China (+33 p.p.) and Taiwan (Chinese) (+2 p.p.) significantly strengthened its position in terms of the total imports, while South Korea and Japan saw its share reduced by -14.4% and -18.8% from 2012 to 2022, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.
In value terms, China ($X) constitutes the largest market for imported vaccines for human medicine in Eastern Asia, comprising 71% of total imports. The second position in the ranking was held by Japan ($X), with an 11% share of total imports. It was followed by South Korea, with an 8.2% share.
In China, vaccine imports increased at an average annual rate of +32.4% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Japan (-2.1% per year) and South Korea (+1.8% per year).
Import Prices by Country
The import price in Eastern Asia stood at $X per ton in 2022, with a decrease of -2.3% against the previous year. In general, the import price, however, enjoyed a strong expansion. The growth pace was the most rapid in 2016 when the import price increased by 26% against the previous year. Over the period under review, import prices hit record highs at $X per ton in 2021, and then contracted modestly in the following year.
Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was China ($X per ton), while Taiwan (Chinese) ($X per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (+15.4%), while the other leaders experienced more modest paces of growth.
Source: IndexBox Platform
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the vaccine market in Eastern Asia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202140 -
- Prodcom 21202145 - Vaccines for human medicine
Country coverage:
- China
- Hong Kong SAR
- Macao SAR
- Japan
- South Korea
- Taiwan (Chinese)
- Democratic People's Republic of Korea
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Production in Eastern Asia, split by region and country
- Trade (exports and imports) in Eastern Asia
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- China
- Hong Kong SAR
- Macao SAR
- Japan
- South Korea
- Taiwan (Chinese)
- Democratic People's Republic of Korea
-
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption, By Country, 2018–2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Destination, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Origin, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Consumption, By Country, 2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Production, By Country, 2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, 2012–2023
Recommended reports
This report provides an in-depth analysis of the vaccine market in Asia.
This report provides an in-depth analysis of the vaccine market in the U.S..
This report provides an in-depth analysis of the vaccine market in China.
This report provides an in-depth analysis of the vaccine market in the EU.
This report provides an in-depth analysis of the global vaccine market.